{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T19:02:56Z","timestamp":1770318176487,"version":"3.49.0"},"reference-count":30,"publisher":"Centers for Disease Control MMWR Office","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm6509e1","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T10:04:51Z","timestamp":1457604291000},"page":"235-241","source":"Crossref","is-referenced-by-count":54,"title":["Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals \u2014 United States, 2014"],"prefix":"10.15585","volume":"65","author":[{"given":"Lindsey M.","family":"Weiner","sequence":"first","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott K.","family":"Fridkin","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuleika","family":"Aponte-Torres","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lacey","family":"Avery","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Coffin","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Dudeck","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan R.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Jernigan","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Konnor","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minn M.","family":"Soe","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Peterson","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Clifford","family":"McDonald","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6224","published-online":{"date-parts":[[2016,3,11]]},"reference":[{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R1","unstructured":"CDC. Antibiotic resistance threats in the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R2","unstructured":"White House. National action plan to combat antibiotic-resistant bacteria. Washington DC: White House; 2015. https:\/\/www.whitehouse.gov\/sites\/default\/files\/docs\/national_action_plan_for_combating_antibotic-resistant_bacteria.pdf"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R3","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1001\/jama.2014.12923","article-title":"Prevalence of antimicrobial use in US acute care hospitals, May-September 2011.","volume":"312","author":"Magill","year":"2014","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R4","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections.","volume":"370","author":"Magill","year":"2014","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R5","unstructured":"US Department of Health and Human Services. National action plan to reduce healthcare-associated infections. Washington DC: US Department of Health and Human Services; 2010. http:\/\/www.hhs.gov\/ash\/initiatives\/hai\/actionplan\/index.html"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R6","unstructured":"CDC. National Healthcare Safety Network: acute care hospital surveillance for central line\u2013associated bloodstream infections. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. http:\/\/www.cdc.gov\/nhsn\/acute-care-hospital\/clabsi\/index.html"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R7","unstructured":"CDC. National Healthcare Safety Network: acute care hospital surveillance for catheter-associated urinary tract infections. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. http:\/\/www.cdc.gov\/nhsn\/acute-care-hospital\/cauti\/index.html"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R8","unstructured":"CDC. National Healthcare Safety Network: acute hospital surveillance for surgical site infections. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. http:\/\/www.cdc.gov\/nhsn\/acute-care-hospital\/ssi\/index.html"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R9","unstructured":"CDC. National and state healthcare associated infections progress report (2012). Atlanta, GA: US Department of Health and Human Services, CDC; 2014. http:\/\/www.cdc.gov\/HAI\/pdfs\/progress-report\/hai-progress-report-2014.pdf"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R10","unstructured":"CDC. National and state healthcare associated infections progress report (2013). Atlanta, GA: US Department of Health and Human Services, CDC; 2015. http:\/\/www.cdc.gov\/hai\/surveillance\/nhsn_nationalreports.html"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R11","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1086\/662016","article-title":"Improving risk-adjusted measures of surgical site infection for the national healthcare safety network.","volume":"32","author":"Mu","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R12","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing; 23rd informational supplement. In: CaLSI, editor. CLSI document M100\u2013S23. Wayne, PA: CLSI; 2013."},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R13","unstructured":"Council of State and Territorial Epidemiologists. Standardized definition for carbapenem-resistant Enterobacteriaceae (CRE) and recommendation for sub-classification and stratified reporting. http:\/\/c.ymcdn.com\/sites\/www.cste.org\/resource\/resmgr\/2015PS\/2015PSFinal\/15-ID-05.pdf"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R14","first-page":"243","article-title":"Vital signs: central line-associated blood stream infections\u2014United States, 2001, 2008, and 2009.","volume":"60","author":"CDC.","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R15","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1377\/hlthaff.2013.0865","article-title":"CDC central-line bloodstream infection prevention efforts produced net benefits of at least $640 Million during 1990\u20132008.","volume":"33","author":"Scott","year":"2014","journal-title":"Health Aff (Millwood)"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States.","volume":"372","author":"Lessa","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R17","first-page":"157","article-title":"Vital signs: preventing Clostridium difficile infections.","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R18","unstructured":"CDC. The five \u201cW\u201ds of the targeted assessment for prevention (TAP) strategy. Atlanta, GA: US Department of Health and Human Services, CDC; 2015. http:\/\/www.cdc.gov\/hai\/prevent\/tap.html"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R19","first-page":"194","article-title":"Vital signs: improving antibiotic use among hospitalized patients.","volume":"63","author":"Fridkin","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R20","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1056\/NEJMoa051590","article-title":"An epidemic, toxin gene-variant strain of Clostridium difficile.","volume":"353","author":"McDonald","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R21","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1086\/595694","article-title":"Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital.","volume":"30","author":"Kallen","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R22","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/cid\/cis614","article-title":"Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.","volume":"55","author":"Wilcox","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1086\/671270","article-title":"Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity.","volume":"34","author":"Swaminathan","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ajic.2011.05.022","article-title":"Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K. pneumoniae.","volume":"40","author":"Borer","year":"2012","journal-title":"Am J Infect Control"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1128\/CMR.00059-12","article-title":"Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?","volume":"26","author":"Beceiro","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1945-1474.2011.00182.x","article-title":"War on the spore: Clostridium difficile disease among patients in a long-term acute care hospital.","volume":"35","author":"Brakovich","year":"2013","journal-title":"J Healthc Qual"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.anaerobe.2009.06.009","article-title":"C. difficile infection (CDI) in a long-term acute care facility (LTAC).","volume":"15","author":"Goldstein","year":"2009","journal-title":"Anaerobe"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R28","unstructured":"Halpin AL, de Man T, Kraft C, Intestinal microbiome disruption in patients in a long-term acute care hospital: a case for development of microbiome disruption indices to improve infection prevention. Am J Infect Control 2016. Available ahead of print. http:\/\/www.ajicjournal.org\/article\/S0196-6553(16)00040-7\/fulltext"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R29","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/cid\/cit500","article-title":"The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.","volume":"57","author":"Lin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.mm6509e1-201603101004-R30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.15585\/mmwr.mm6430a4","article-title":"Vital signs: Estimated effects of a coordinated approach for action to reduce antibiotic-resistant infections in health care facilities\u2014United States.","volume":"64","author":"Slayton","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T10:04:51Z","timestamp":1457604291000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/65\/wr\/mm6509e1.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,11]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,3,11]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm6509e1","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,11]]}}}